Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection
about
Herbal products: benefits, limits, and applications in chronic liver diseaseIdentification of hepatoprotective flavonolignans from silymarinPotential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic InfectionSilymarin for HCV infectionProtective effect of silymarin against chemical-induced cardiotoxicityDifferential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells.Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.Complementary and alternative medications in hepatitis C infection.Silybin and the liver: from basic research to clinical practice."Silymarin", a promising pharmacological agent for treatment of diseasesSustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics.Phylogenetic and chemical diversity of fungal endophytes isolated from Silybum marianum (L) Gaertn. (milk thistle)Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CFailure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft ReinfectionSilymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cellsSilymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial.Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress SignalingHepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection.Absolute configuration of isosilybin A by X-ray crystallography of the heavy atom analogue 7-(4-Bromobenzoyl)isosilybin AEnhanced bioactivity of silybin B methylation productsSilymarin content in Silybum marianum populations growing in Egypt.Impact of oral silymarin on virus- and non-virus-specific T-cell responses in chronic hepatitis C infectionEffect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialA validated UHPLC-tandem mass spectrometry method for quantitative analysis of flavonolignans in milk thistle (Silybum marianum) extracts.Inhibition of HIV by Legalon-SIL is independent of its effect on cellular metabolism.Hepatitis C virus and natural compounds: a new antiviral approach?Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases.Multiple effects of silymarin on the hepatitis C virus lifecycle.Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy.Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production.Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3β Inhibition-Induced Reduction of VEGF Release.Proliferative and Anti-Inflammatory Effects of Resveratrol and Silymarin on Human Gingival Fibroblasts: A View to the Future.Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats.Antiviral Activities of Oleanolic Acid and Its AnaloguesThe Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis
P2860
Q21284956-E1ED2FB0-8A98-4046-BC56-BE1A3B74E90AQ24600492-C6F41133-B35C-4704-99DE-120032DF1D6CQ26753151-48F0F0DF-306F-4A12-A1F9-3EFD874954C6Q26775036-BD90C604-B60F-4522-91DB-BC4CC25D4CF0Q26851453-E4A3028F-07B5-42BB-A332-513F8F7EEEE4Q28079909-22622D42-27A0-4ECF-A261-9256D7934FC7Q30997889-71D2607E-1F9E-41CD-A246-217A967F10E6Q34027884-0FD7B0DE-E2C2-45D2-BB0D-8B5CD94302A9Q34359120-09E1E390-A5E5-45BD-A7E8-85D657F3AFAEQ34411345-B407E334-171C-4109-9068-E39C5BA974CAQ34629765-B2BC4277-C318-4043-9303-3E2AD0971ADDQ34649335-5A67D8DB-7D2E-46CB-B65D-34D905FC5D66Q35007560-7A5A5B33-0556-44AD-9508-B97AFBB55EA0Q35535691-68080DD8-119B-4C80-92E9-8D8A672349DFQ35800747-EAD38C84-B7F3-4B70-BF6C-B19EAD37207CQ36142772-86883E79-2350-4D46-BF29-09D749146E98Q36269639-19CB5D5B-E54D-4A29-BA93-F25A7B78CA14Q36374902-9B7859D4-3DC2-413F-B1FB-53E3D752FA55Q36435673-6E6F3E8B-E047-4833-8226-D04E9106E252Q36675737-ED48DDEF-887F-4CC0-954D-AD69556BD44CQ36750919-1A13F862-6EF9-4D2D-AF36-E539CF89A984Q36778757-5DC09235-7A53-4A0B-A3B7-CAF8923519AEQ36891591-D1DA1605-E338-4CAC-B115-05119A068C6BQ36910728-FEFAF581-3402-4D38-B17E-97197756A2F9Q36933129-80717B4C-7042-4E97-BEC7-267D55FE00D4Q36971126-05D975AF-72A2-4CC9-8ADE-5430069258A9Q37539831-8FC3B8C6-7D24-4E0E-AD19-523C59DD9FC4Q38064280-EBC883CA-9DD9-4C47-B80A-39A76C080A26Q38341299-CDB07A8A-4F1A-4BB8-80A6-8333365A0485Q39413230-29306D1F-AE0A-4C3D-ABE2-F94FEB3C7E7AQ39526307-E90F1DF4-1C47-48D4-B8F9-46CC9C0B39C5Q39698364-24196BBD-7C13-4128-ACD0-20C61A7E9C67Q40641829-689A6037-F8B4-474B-8DE9-77DCC172D0A4Q44403427-A31AAD09-37AC-4573-AEC6-F287DB54C8A9Q47133435-7ECE4C4E-76DC-4EBD-BABE-DF7E89D2BA46Q47137891-0ED2655F-73CB-4800-A09A-E60B2846F56AQ49830490-7B1EEE66-E9E6-4069-A3FF-EEA04215379EQ58691294-3A6F48CA-E7C7-4461-A99C-748DBFE8413FQ58769263-DAD6C148-4706-4392-876F-FEA02499B5B2
P2860
Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Silymarin Inhibits In Vitro T- ...... in Hepatitis C Virus Infection
@nl
Silymarin inhibits in vitro T- ...... in hepatitis C virus infection
@ast
Silymarin inhibits in vitro T- ...... in hepatitis C virus infection
@en
type
label
Silymarin Inhibits In Vitro T- ...... in Hepatitis C Virus Infection
@nl
Silymarin inhibits in vitro T- ...... in hepatitis C virus infection
@ast
Silymarin inhibits in vitro T- ...... in hepatitis C virus infection
@en
prefLabel
Silymarin Inhibits In Vitro T- ...... in Hepatitis C Virus Infection
@nl
Silymarin inhibits in vitro T- ...... in hepatitis C virus infection
@ast
Silymarin inhibits in vitro T- ...... in hepatitis C virus infection
@en
P2093
P2860
P1433
P1476
Silymarin inhibits in vitro T- ...... in hepatitis C virus infection
@en
P2093
Chia C Wang
Chihiro Morishima
David Y-W Lee
Denise M Paschal
Derek D Sloan
Keith R Jerome
Margaret C Shuhart
Minjun C Apodaca
Nicholas H Oberlies
Stephen J Polyak
P2860
P304
671-81, 681.e1-2
P356
10.1053/J.GASTRO.2009.09.021
P407
P577
2009-09-24T00:00:00Z